top of page
Screen Shot 2021-04-01 at 8.19.46 PM.png
Miami.png
Futurism.png
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Depositphotos_23805129_s-2019.jpg

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

PsyBio Therapeutics Corp. (TSXV: PSYB) ("PsyBio" or the "Company"), a leader in the field of psychedelic ...

Read More
Screen Shot 2021-04-01 at 8.19.46 PM.png
Screen Shot 2021-04-01 at 8.19.46 PM.png
Miami.png
2021-03-01 (1).png

Dr. Jones is one of AIChE's 35 Under 35

The American Institute of Chemical Engineers (AIChE) has selected its latest group of engineers for their 35 Under 35 Award, and Dr. J...

Read More
Image by ThisisEngineering RAEng

PsyBio Therapeutics Announces Retention of Market Maker

PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company”), a leader in the field of psychedelic...

Read More
Microscope_edited.jpg

PsyBio Therapeutics Virtually Closes the Market

Evan Levine, Chief Executive Officer, PsyBio Therapeutics Corp. ("PsyBio" or "the Company") (TSXV: PSYB) and his team joined Dani Lipkin, Director, Global Business Development

Read More
bottom of page